Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61


Effects of HIV and Methamphetamine on Brain and Behavior: Evidence from Human Studies and Animal Models.

Soontornniyomkij V, Kesby JP, Morgan EE, Bischoff-Grethe A, Minassian A, Brown GG, Grant I; Translational Methamphetamine AIDS Research Center (TMARC) Group.

J Neuroimmune Pharmacol. 2016 Sep;11(3):495-510. doi: 10.1007/s11481-016-9699-0. Epub 2016 Aug 2. Review.


White matter deficits assessed by diffusion tensor imaging and cognitive dysfunction in psychostimulant users with comorbid human immunodeficiency virus infection.

Tang VM, Lang DJ, Giesbrecht CJ, Panenka WJ, Willi T, Procyshyn RM, Vila-Rodriguez F, Jenkins W, Lecomte T, Boyda HN, Aleksic A, MacEwan GW, Honer WG, Barr AM.

BMC Res Notes. 2015 Sep 30;8:515. doi: 10.1186/s13104-015-1501-5.


Neuronal-Glia Markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral Therapy.

Sailasuta N, Ananworanich J, Lerdlum S, Sithinamsuwan P, Fletcher JL, Tipsuk S, Pothisri M, Jadwattanakul T, Jirajariyavej S, Chalermchai T, Catella S, Busovaca E, Desai A, Paul R, Valcour V; SEARCH 011 Study Group.

J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):24-30. doi: 10.1097/QAI.0000000000000779.


Methamphetamine effects on blood-brain barrier structure and function.

Northrop NA, Yamamoto BK.

Front Neurosci. 2015 Mar 4;9:69. doi: 10.3389/fnins.2015.00069. eCollection 2015. Review.


Independent effects of HIV infection and cocaine dependence on neurocognitive impairment in a community sample living in the southern United States.

Meade CS, Towe SL, Skalski LM, Robertson KR.

Drug Alcohol Depend. 2015 Apr 1;149:128-35. doi: 10.1016/j.drugalcdep.2015.01.034. Epub 2015 Feb 7.


Methamphetamine Exposure Combined with HIV-1 Disease or gp120 Expression: Comparison of Learning and Executive Functions in Humans and Mice.

Kesby JP, Heaton RK, Young JW, Umlauf A, Woods SP, Letendre SL, Markou A, Grant I, Semenova S.

Neuropsychopharmacology. 2015 Jul;40(8):1899-909. doi: 10.1038/npp.2015.39. Epub 2015 Feb 5.


Independent and co-morbid HIV infection and Meth use disorders on oxidative stress markers in the cerebrospinal fluid and depressive symptoms.

Panee J, Pang X, Munsaka S, Berry MJ, Chang L.

J Neuroimmune Pharmacol. 2015 Mar;10(1):111-21. doi: 10.1007/s11481-014-9581-x. Epub 2015 Jan 10.


Cognitive deficits associated with combined HIV gp120 expression and chronic methamphetamine exposure in mice.

Kesby JP, Markou A, Semenova S; Translational Methamphetamine AIDS Research Center (TMARC) Group.

Eur Neuropsychopharmacol. 2015 Jan;25(1):141-50. doi: 10.1016/j.euroneuro.2014.07.014. Epub 2014 Aug 4.


Neuroimmune basis of methamphetamine toxicity.

Loftis JM, Janowsky A.

Int Rev Neurobiol. 2014;118:165-97. doi: 10.1016/B978-0-12-801284-0.00007-5. Review.


Detrimental impact of remote methamphetamine dependence on neurocognitive and everyday functioning in older but not younger HIV+ adults: evidence for a legacy effect?

Iudicello JE, Morgan EE, Gongvatana A, Letendre SL, Grant I, Woods SP; Translational Methamphetamine AIDS Research Center (TMARC) Group.

J Neurovirol. 2014 Feb;20(1):85-98. doi: 10.1007/s13365-014-0233-y. Epub 2014 Jan 28.


"Frontal systems" behaviors in comorbid human immunodeficiency virus infection and methamphetamine dependency.

Marquine MJ, Iudicello JE, Morgan EE, Brown GG, Letendre SL, Ellis RJ, Deutsch R, Woods SP, Grant I, Heaton RK; Translational Methamphetamine AIDS Research Center (TMARC) Group.

Psychiatry Res. 2014 Jan 30;215(1):208-16. doi: 10.1016/j.psychres.2013.11.004. Epub 2013 Nov 13.


Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine.

Henry BL, Geyer MA, Buell MR, Perry W, Young JW, Minassian A; Translational Methamphetamine AIDS Research Center (TMARC) Group.

Behav Pharmacol. 2014 Feb;25(1):12-22. doi: 10.1097/FBP.0000000000000012.


Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain.

Chang L, Munsaka SM, Kraft-Terry S, Ernst T.

J Neuroimmune Pharmacol. 2013 Jun;8(3):576-93. doi: 10.1007/s11481-013-9460-x. Epub 2013 May 12. Review.


Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposure.

McClay JL, Adkins DE, Vunck SA, Batman AM, Vann RE, Clark SL, Beardsley PM, van den Oord EJ.

Metabolomics. 2013 Apr 1;9(2):392-402. Epub 2012 Aug 26.


Regional variations of antioxidant capacity and oxidative stress responses in HIV-1 transgenic rats with and without methamphetamine administration.

Pang X, Panee J, Liu X, Berry MJ, Chang SL, Chang L.

J Neuroimmune Pharmacol. 2013 Jun;8(3):691-704. doi: 10.1007/s11481-013-9454-8. Epub 2013 Apr 2.


Decreased frontal N-acetylaspartate levels in adolescents concurrently using both methamphetamine and marijuana.

Sung YH, Carey PD, Stein DJ, Ferrett HL, Spottiswoode BS, Renshaw PF, Yurgelun-Todd DA.

Behav Brain Res. 2013 Jun 1;246:154-61. doi: 10.1016/j.bbr.2013.02.028. Epub 2013 Mar 4.


Prospective memory in HIV-associated neurocognitive disorders (HAND): the neuropsychological dynamics of time monitoring.

Doyle KL, Loft S, Morgan EE, Weber E, Cushman C, Johnston E, Grant I, Woods SP; Hiv Neurobehavioral Research Program Hnrp Group.

J Clin Exp Neuropsychol. 2013;35(4):359-72. doi: 10.1080/13803395.2013.776010. Epub 2013 Mar 7.


HIV and recent illicit drug use interact to affect verbal memory in women.

Meyer VJ, Rubin LH, Martin E, Weber KM, Cohen MH, Golub ET, Valcour V, Young MA, Crystal H, Anastos K, Aouizerat BE, Milam J, Maki PM.

J Acquir Immune Defic Syndr. 2013 May 1;63(1):67-76. doi: 10.1097/QAI.0b013e318289565c.


Decreased frontal lobe phosphocreatine levels in methamphetamine users.

Sung YH, Yurgelun-Todd DA, Shi XF, Kondo DG, Lundberg KJ, McGlade EC, Hellem TL, Huber RS, Fiedler KK, Harrell RE, Nickerson BR, Kim SE, Jeong EK, Renshaw PF.

Drug Alcohol Depend. 2013 Apr 1;129(1-2):102-9. doi: 10.1016/j.drugalcdep.2012.09.015. Epub 2012 Oct 18.

Items per page

Supplemental Content

Write to the Help Desk